Archive

Post Archive: Clinical Trials and Research

Virginia Cancer Specialists » Practice News » Clinical Trials and Research

Announcing the upcoming opening of the MMRC MyDRUG clinical trial, which will enroll patients with recurrent Multiple Myeloma

December 12, 2018
Read More

Lung Cancer and Clinical Trial News, Alex Spira, M.D., PhD, F.A.C.P.

November 26, 2018
Read More

Trial Underway for Checkpoint Blockade in Soft Tissue Sarcoma - Felafsa Wodajo, MD

October 8, 2018
Read More

Advancements in Science and Cancer Care Research Announced at the US Oncology Research 17th Annual Science Forum - Dr. Alex Spira

October 8, 2018
Read More

Virginia Cancer Specialists Collaborating with Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual Meeting

May 22, 2018
Read More

Dr. Alex Spira quoted in announcement from Mirati Theraputics: Progress Of Lead Programs And Updated Positive Clinical Trial Results For Immuno-Oncology Combination Trials

April 26, 2018
Read More

Virginia Cancer Specialists first patient successfully completes Cycle 1 of Treatment with PCM-075 combination with Low Dose Cytarabine (LDAC) AML Trial

March 6, 2018
Read More

Patient Safety for Clinical Trials is important, here are four questions to ask

February 7, 2018
Read More

Virginia Cancer Specialists enrolls fist patient in Phase 1b/2 Clinical Trial of PCM-075 for Acute Myeloid Leukemia (AML)

February 7, 2018
Read More

Two promising new Drugs are available in a Clinical Trial Offered by Virginia Cancer Specialists

September 26, 2017
Read More